Solutions tailored for smarter execution
MedExport Asia ensures smarter execution by delivering solutions built for lower risk, faster timelines, and sustainable growth.
-
Market-access design and commercial prioritization based on real opportunities than can win.
-
Easily connect with 400+ ASEAN companies and extended networks across EU, MENA, and LATAM.
-
Portfolio validation for regulatory alignment and commercial feasibility across regional markets.
-
Organization of targeted meetings with qualified distributors, licensees, and key stakeholders.
-
Support in structuring, negotiating, and finalizing licensing and distribution agreements.
-
Commercial representation for companies requiring active follow-up and ongoing engagement.
-
Cross-border BD support with trusted partners for LATAM, MENA, and US retail/wholesale entry.
-
Competitor intelligence and commercial insights to guide market entry and pricing strategies.
-
Post-market monitoring of early distributor performance and contractual alignment.
-
-
Scouting innovative or hard-to-manufacture products from EU/US-approved GMP or PIC/S-certified global partners.
-
Collaboration with reliable manufacturing partners and CDMOs across China, India, Taiwan, Europe, and more.
-
Differentiated, first-to-market, clinically supported, or value-added products — no commodities.
-
Monitoring of development pipelines to identify future high-value products for early advantage.
-
Assessing ACTD/CTD/Technical File readiness to support sourcing decisions and future pipeline.
-
Identifying and securing commercial partnerships with manufacturers and/or IP holders.
-
Supporting negotiation and finalization of licensing, supply, or other commercial agreements.
-
Providing advisory for Tender and Private sector channels to ensure correct positioning.
-
Organization of targeted meetings with key decision-makers and relevant stakeholders.
-
Coordinating onboarding between buyers and suppliers to ensure smooth alignment.
-
-
Portfolio evaluation for regulatory alignment, classification, grouping, and commercial interest.
-
Competitor intelligence, reimbursement insights, and tender/private-sector pricing strategies.
-
Dossier gap-analysis, adaptation for local requirements, and full pre-submission technical advisory.
-
Local BE strategy, biowaiver assessment, study design, cost evaluation, and CRO recommendations.
-
Official Thai FDA consultation, pre-submission meetings, and coordination of product registration.
-
Local license holding and regulatory execution through Thai FDA–licensed partners.
-
Lifecycle activities including variations, renewals, and post-approval commitments.
-
Targeted introductions and partnership engagement with top-tier and mid-sized players.
-
Support in structuring, negotiating, and closing licensing and distribution agreements.
-
Early post-market monitoring of distributor performance and contract alignment.
-
Snapshot in numbers
4,000+
Global Pharma Industry Contacts
400+
Asia-Specific Companies
100+
Cross-Border Projects
Core Product Areas
Innovative & New Chemical Entities
Value-Added & Complex Generics
First-to-Market Generics
Biologics & Advanced Therapeutics
Biosimilars
Oncology
Ophthalmics
Innovative Medical Devices
Nutraceuticals & Medical Nutrition
Enabling pharmaceutical companies to build strong and competitive portfolios through strategic partnerships.